brimonidine tartrate has been researched along with Chronic Illness in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, J; Zhang, T; Zhou, X | 1 |
| Jung, KI; Kim, JH; Park, CK | 1 |
| Bhikoo, R; Botha, VE; Merriman, M | 1 |
| Donald, CB; Mendez, AP; Pierce, BD | 1 |
| Arrico, L; Di Staso, S; Giuffrè, I; Recupero, SM; Taverniti, L | 1 |
| Susanna, R; Vaidergorn, PG | 1 |
| Flügge, G | 1 |
| Assalian, A; Chevrier, RL; Duperré, J; Lesk, MR | 1 |
| Cha, SC; Glover, BK; Kim, C; Kim, YY; Nguyen, KD; Shin, DH | 1 |
| Coats, P; Hillier, C; Jarajapu, YP; MacDonald, A; McGrath, JC | 1 |
| Bogers, JJ; De Man, JG; De Winter, BY; Herman, AG; Moreels, TG; Pelckmans, PA; Van Marck, EA | 1 |
| Ruiz, G; Wheeler, LA; Wijono, M; WoldeMussie, E | 1 |
| Earl, ML; Simmons, ST | 1 |
3 trial(s) available for brimonidine tartrate and Chronic Illness
| Article | Year |
|---|---|
Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Brimonidine Tartrate; Chronic Disease; Clonidine; Female; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Male; Middle Aged; Observer Variation; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Trabeculectomy; Treatment Outcome | 1999 |
Long-term brimonidine therapy in glaucoma patients with apraclonidine allergy.
Topics: Adrenergic alpha-Agonists; Aged; Brimonidine Tartrate; Chronic Disease; Clonidine; Drug Hypersensitivity; Female; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Quinoxalines | 1999 |
Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Brimonidine Tartrate; Chronic Disease; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Quality of Life; Quinoxalines; Treatment Outcome | 2002 |
10 other study(ies) available for brimonidine tartrate and Chronic Illness
| Article | Year |
|---|---|
Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Chronic Disease; Disease Models, Animal; Excitatory Postsynaptic Potentials; Glaucoma; Intraocular Pressure; Male; Membrane Potentials; Patch-Clamp Techniques; Presynaptic Terminals; Rats; Rats, Wistar; Retinal Ganglion Cells; Synaptic Transmission | 2019 |
α2-Adrenergic modulation of the glutamate receptor and transporter function in a chronic ocular hypertension model.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Biological Transport; Brimonidine Tartrate; Chronic Disease; Excitatory Amino Acid Transporter 1; Glaucoma; Glial Fibrillary Acidic Protein; Glutamic Acid; Intraocular Pressure; Male; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Glutamate | 2015 |
Venlafaxine-induced intraocular pressure rise in a patient with open angle glaucoma.
Topics: Antidepressive Agents, Second-Generation; Antihypertensive Agents; Brimonidine Tartrate; Chronic Disease; Depressive Disorder; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Tonometry, Ocular; Venlafaxine Hydrochloride | 2016 |
Eye problems in a woman with Churg-Strauss syndrome.
Topics: Administration, Ophthalmic; Antihypertensive Agents; Brimonidine Tartrate; Chronic Disease; Churg-Strauss Syndrome; Edema; Exophthalmos; Eye Diseases; Eyelids; Female; Glucocorticoids; Humans; Latanoprost; Methylprednisolone; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic | 2017 |
Effect of brimonidine on patients undergoing uncontrolled IOP with beta-blockers.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Brimonidine Tartrate; Chronic Disease; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Prospective Studies; Quinoxalines; Treatment Failure | 2002 |
Argon laser trabeculoplasty and reduction of ocular hypotensive medication used by glaucoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Chronic Disease; Circadian Rhythm; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Male; Middle Aged; Quinoxalines; Trabeculectomy; Treatment Outcome | 2006 |
Alterations in the central nervous alpha 2-adrenoceptor system under chronic psychosocial stress.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Chronic Disease; Down-Regulation; Hydrocortisone; Idazoxan; Locus Coeruleus; Male; Nerve Tissue Proteins; Norepinephrine; Oxymetazoline; Pituitary-Adrenal System; Prefrontal Cortex; Quinoxalines; Receptors, Adrenergic, alpha-2; Social Dominance; Solitary Nucleus; Stress, Psychological; Tupaiidae; Up-Regulation; Vagus Nerve | 1996 |
Increased alpha(1)- and alpha(2)-adrenoceptor-mediated contractile responses of human skeletal muscle resistance arteries in chronic limb ischemia.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Arteries; Brimonidine Tartrate; Chronic Disease; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Ischemia; Leg; Male; Middle Aged; Muscle, Skeletal; Norepinephrine; Quinoxalines; Receptors, Adrenergic, alpha; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Disturbance of the prejunctional modulation of cholinergic neurotransmission during chronic granulomatous inflammation of the mouse ileum.
Topics: Adrenergic Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Antagonists; Animals; Brimonidine Tartrate; Carbachol; Cholinergic Agents; Cholinergic Agonists; Cholinergic Antagonists; Chronic Disease; Dimethylphenylpiperazinium Iodide; Dose-Response Relationship, Drug; Electric Stimulation; Granuloma; Hexamethonium; Histamine; Histamine Agonists; Histamine Antagonists; Ileum; In Vitro Techniques; Male; Mice; Muscle Contraction; Neuromuscular Junction; Peroxidase; Quinoxalines; Receptors, Histamine; Schistosoma mansoni; Schistosomiasis mansoni; Synaptic Transmission; Tetrodotoxin | 2001 |
Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Brimonidine Tartrate; Cell Survival; Chronic Disease; Cytoprotection; Glial Fibrillary Acidic Protein; Intraocular Pressure; Laser Coagulation; Male; Neuroprotective Agents; Ocular Hypertension; Quinoxalines; Rats; Rats, Wistar; Retina; Retinal Ganglion Cells; Time Factors; Timolol | 2001 |